Clinical Trial Update: Glucagon-like Peptide 1 (GLP-1) and Endothelial Dysfunction in Metabolic Syndrome [NA]

View source ↗

Summary

This document notes the completed status of a clinical trial examining GLP-1 and endothelial dysfunction in metabolic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Snippet

Sponsor: University of Rome Tor Vergata | Conditions: Metabolic Syndrome | NA | Status: COMPLETED